Story perspectives
Breakthrough Molecule Offers Hope for Down Syndrome Treatment
10/31/2025
1 of 1
Story summary
- Researchers at the Salk Institute identified pleiotrophin as a potential treatment for faulty brain circuits in Down syndrome.
- Pleiotrophin is a molecule crucial for nervous system development and has shown promise by improving brain function in adult mice.
- The study suggests delivering pleiotrophin via astrocytes could enhance brain plasticity.
- Researchers note that this approach may extend to other neurological disorders, including Alzheimer’s disease, but more studies are required.
